Sun Pharma, Lupin recall drugs in US market: USFDA

Sun Pharmaceutical is recalling the affected lot that was produced at the drugmaker's Dadra-based facility. The company is recalling the lot due to "failed impurities/degradation specifications", the USFDA stated. USFDA stated that Mumbai-based Lupin is also recalling an unspecified number of penicillamine tablets in the US.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/lIikrVf
via IFTTT